InspireMD seeks to raise roughly $8 million through a direct offering to help fund development of its MGuard and CGuard stent platforms.
InspireMD (OTC:NSPR) said it's seeking to raise roughly $8 million via a direct offering to help fund development of its MGuard and CGuard stent platforms.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1yYxTRV
Cap comentari:
Publica un comentari a l'entrada